Remove Drugs Remove Pharma R&D Remove Research
article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

Developing a new drug is a monumental achievement — the reward of years of research and innovation. Successful innovation requires enormous effort from countless project teams that build on the medical, scientific and technological research and development of generations before them.

article thumbnail

Transforming pharma R&D with a scientist-centric approach to AI & automation

pharmaphorum

Deloitte anticipates that the next five years could see AI dramatically accelerating the drug discovery process. With a scientist-centric mindset, we believe R&D can be transformed in a far shorter timeframe. About the author. Markus has a PhD in Plant Biochemistry from Durham.

article thumbnail

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

The Pharma Data

.–( BUSINESS WIRE )– Boehringer Ingelheim announced today a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations.